(SZU) Südzucker - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE0007297004
Stock: Sugar, Ethanol, Starch, Fruit Preparations, Juice Concentrates
Total Rating 26
Risk 86
Buy Signal -1.43
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.00% |
| Yield on Cost 5y | 1.96% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 87.0% |
| Payout Ratio | 409.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.2% |
| Relative Tail Risk | -1.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.37 |
| Alpha | -8.66 |
| Character TTM | |
|---|---|
| Beta | -0.014 |
| Beta Downside | -0.013 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.67% |
| CAGR/Max DD | -0.26 |
Description: SZU Südzucker January 13, 2026
Südzucker AG (XETRA:SZU) is a German-based, vertically integrated producer of sugar and related specialty products. It operates across five segments – Sugar, Special Products, CropEnergies, Starch, and Fruit – supplying commodities and functional ingredients to food, beverage, animal-feed, pharmaceutical, and industrial markets worldwide.
Key metrics: the group generated roughly €6.5 bn of revenue in FY 2023 with an adjusted EBITDA margin of about 12 %; its CropEnergies unit contributed ~15 % of total sales, reflecting the growing importance of bio-ethanol as a renewable fuel. Core drivers include EU sugar price cycles (influenced by the 2021 quota removal), rising demand for low-calorie sweeteners and dietary fibers, and the broader shift toward sustainable raw materials in the food-processing chain.
For a deeper, data-rich view of Südzucker’s valuation dynamics, you may want to explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -168.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -3.97 > 1.0 |
| NWC/Revenue: 20.63% < 20% (prev 18.29%; Δ 2.34% < -1%) |
| CFO/TA 0.05 > 3% & CFO 468.0m > Net Income -168.0m |
| Net Debt (2.88b) to EBITDA (2.27b): 1.27 < 3 |
| Current Ratio: 1.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (204.2m) vs 12m ago 6.38% < -2% |
| Gross Margin: 83.40% > 18% (prev 0.80%; Δ 8259 % > 0.5%) |
| Asset Turnover: 95.27% > 50% (prev 108.7%; Δ -13.47% > 0%) |
| Interest Coverage Ratio: -1.18 > 6 (EBITDA TTM 2.27b / Interest Expense TTM 137.0m) |
Altman Z'' 1.97
| A: 0.20 (Total Current Assets 4.35b - Total Current Liabilities 2.58b) / Total Assets 8.84b |
| B: 0.10 (Retained Earnings 859.0m / Total Assets 8.84b) |
| C: -0.02 (EBIT TTM -162.0m / Avg Total Assets 9.01b) |
| D: 0.44 (Book Value of Equity 2.52b / Total Liabilities 5.75b) |
| Altman-Z'' Score: 1.97 = BBB |
Beneish M -3.30
| DSRI: 0.93 (Receivables 972.0m/1.21b, Revenue 8.58b/9.98b) |
| GMI: 0.97 (GM 83.40% / 80.48%) |
| AQI: 0.98 (AQ_t 0.12 / AQ_t-1 0.13) |
| SGI: 0.86 (Revenue 8.58b / 9.98b) |
| TATA: -0.07 (NI -168.0m - CFO 468.0m) / TA 8.84b) |
| Beneish M-Score: -3.30 (Cap -4..+1) = AA |
What is the price of SZU shares?
As of February 07, 2026, the stock is trading at EUR 9.66 with a total of 147,588 shares traded.
Over the past week, the price has changed by -0.10%, over one month by +5.87%, over three months by +0.84% and over the past year by -5.26%.
Over the past week, the price has changed by -0.10%, over one month by +5.87%, over three months by +0.84% and over the past year by -5.26%.
Is SZU a buy, sell or hold?
Südzucker has no consensus analysts rating.
What are the forecasts/targets for the SZU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.7 | 0.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 9.5 | -1.3% |
SZU Fundamental Data Overview February 02, 2026
Market Cap USD = 2.25b (1.90b EUR * 1.1801 EUR.USD)
P/E Forward = 15.9744
P/S = 0.2299
P/B = 0.6309
P/EG = 0.75
Revenue TTM = 8.58b EUR
EBIT TTM = -162.0m EUR
EBITDA TTM = 2.27b EUR
Long Term Debt = 1.36b EUR (from longTermDebt, last quarter)
Short Term Debt = 814.0m EUR (from shortTermDebt, last quarter)
Debt = 2.88b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.88b EUR (from netDebt column, last quarter)
Enterprise Value = 4.02b EUR (1.90b + Debt 2.88b - CCE 766.0m)
Interest Coverage Ratio = -1.18 (Ebit TTM -162.0m / Interest Expense TTM 137.0m)
EV/FCF = -365.3x (Enterprise Value 4.02b / FCF TTM -11.0m)
FCF Yield = -0.27% (FCF TTM -11.0m / Enterprise Value 4.02b)
FCF Margin = -0.13% (FCF TTM -11.0m / Revenue TTM 8.58b)
Net Margin = -1.96% (Net Income TTM -168.0m / Revenue TTM 8.58b)
Gross Margin = 83.40% ((Revenue TTM 8.58b - Cost of Revenue TTM 1.43b) / Revenue TTM)
Gross Margin QoQ = none% (prev 30.35%)
Tobins Q-Ratio = 0.45 (Enterprise Value 4.02b / Total Assets 8.84b)
Interest Expense / Debt = 0.94% (Interest Expense 27.0m / Debt 2.88b)
Taxrate = 50.0% (3.00m / 6.00m)
NOPAT = -81.0m (EBIT -162.0m * (1 - 50.00%)) [loss with tax shield]
Current Ratio = 1.69 (Total Current Assets 4.35b / Total Current Liabilities 2.58b)
Debt / Equity = 1.18 (Debt 2.88b / totalStockholderEquity, last quarter 2.43b)
Debt / EBITDA = 1.27 (Net Debt 2.88b / EBITDA 2.27b)
Debt / FCF = -261.9 (out of range, set to none) (Net Debt 2.88b / FCF TTM -11.0m)
Total Stockholder Equity = 3.02b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.86% (Net Income -168.0m / Total Assets 8.84b)
RoE = -5.57% (Net Income TTM -168.0m / Total Stockholder Equity 3.02b)
RoCE = -3.70% (EBIT -162.0m / Capital Employed (Equity 3.02b + L.T.Debt 1.36b))
RoIC = -2.03% (negative operating profit) (NOPAT -81.0m / Invested Capital 3.98b)
WACC = 2.61% (E(1.90b)/V(4.78b) * Re(5.86%) + D(2.88b)/V(4.78b) * Rd(0.94%) * (1-Tc(0.50)))
Discount Rate = 5.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
Fair Price DCF = unknown (Cash Flow -11.0m)
EPS Correlation: -64.47 | EPS CAGR: -4.99% | SUE: -4.0 | # QB: 0
Revenue Correlation: -15.56 | Revenue CAGR: 2.58% | SUE: -0.04 | # QB: 0
EPS next Year (2027-02-28): EPS=0.48 | Chg30d=-0.378 | Revisions Net=-3 | Growth EPS=+2981.1% | Growth Revenue=+2.4%
P/E Forward = 15.9744
P/S = 0.2299
P/B = 0.6309
P/EG = 0.75
Revenue TTM = 8.58b EUR
EBIT TTM = -162.0m EUR
EBITDA TTM = 2.27b EUR
Long Term Debt = 1.36b EUR (from longTermDebt, last quarter)
Short Term Debt = 814.0m EUR (from shortTermDebt, last quarter)
Debt = 2.88b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.88b EUR (from netDebt column, last quarter)
Enterprise Value = 4.02b EUR (1.90b + Debt 2.88b - CCE 766.0m)
Interest Coverage Ratio = -1.18 (Ebit TTM -162.0m / Interest Expense TTM 137.0m)
EV/FCF = -365.3x (Enterprise Value 4.02b / FCF TTM -11.0m)
FCF Yield = -0.27% (FCF TTM -11.0m / Enterprise Value 4.02b)
FCF Margin = -0.13% (FCF TTM -11.0m / Revenue TTM 8.58b)
Net Margin = -1.96% (Net Income TTM -168.0m / Revenue TTM 8.58b)
Gross Margin = 83.40% ((Revenue TTM 8.58b - Cost of Revenue TTM 1.43b) / Revenue TTM)
Gross Margin QoQ = none% (prev 30.35%)
Tobins Q-Ratio = 0.45 (Enterprise Value 4.02b / Total Assets 8.84b)
Interest Expense / Debt = 0.94% (Interest Expense 27.0m / Debt 2.88b)
Taxrate = 50.0% (3.00m / 6.00m)
NOPAT = -81.0m (EBIT -162.0m * (1 - 50.00%)) [loss with tax shield]
Current Ratio = 1.69 (Total Current Assets 4.35b / Total Current Liabilities 2.58b)
Debt / Equity = 1.18 (Debt 2.88b / totalStockholderEquity, last quarter 2.43b)
Debt / EBITDA = 1.27 (Net Debt 2.88b / EBITDA 2.27b)
Debt / FCF = -261.9 (out of range, set to none) (Net Debt 2.88b / FCF TTM -11.0m)
Total Stockholder Equity = 3.02b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.86% (Net Income -168.0m / Total Assets 8.84b)
RoE = -5.57% (Net Income TTM -168.0m / Total Stockholder Equity 3.02b)
RoCE = -3.70% (EBIT -162.0m / Capital Employed (Equity 3.02b + L.T.Debt 1.36b))
RoIC = -2.03% (negative operating profit) (NOPAT -81.0m / Invested Capital 3.98b)
WACC = 2.61% (E(1.90b)/V(4.78b) * Re(5.86%) + D(2.88b)/V(4.78b) * Rd(0.94%) * (1-Tc(0.50)))
Discount Rate = 5.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
Fair Price DCF = unknown (Cash Flow -11.0m)
EPS Correlation: -64.47 | EPS CAGR: -4.99% | SUE: -4.0 | # QB: 0
Revenue Correlation: -15.56 | Revenue CAGR: 2.58% | SUE: -0.04 | # QB: 0
EPS next Year (2027-02-28): EPS=0.48 | Chg30d=-0.378 | Revisions Net=-3 | Growth EPS=+2981.1% | Growth Revenue=+2.4%